Country: United States
Language: English
Source: NLM (National Library of Medicine)
NITROFURANTOIN (UNII: 927AH8112L) (NITROFURANTOIN - UNII:927AH8112L)
Lifestar Pharma LLC
ORAL
PRESCRIPTION DRUG
Nitrofurantoin capsules (macrocrystals) are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli , enterococci, Staphylococcus aureus , and certain susceptible strains of Klebsiella and Enterobacter species. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules (macrocrystals) and other antibacterial drugs, nitrofurantoin capsules (macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Nitrofurantoins lack the broader tissue distribution of other the
Nitrofurantoin capsules, USP (macrocrystals) are available as follows: 25 mg white opaque cap and white opaque body, hard gelatin size "5" capsules imprinted with "LS" on cap and "410" on body with black ink, containing light yellow to yellow colored powder. NDC 70756-410-11 Bottle of 100 with child-resistant closure 50 mg blue opaque cap and white opaque body, hard gelatin size "3" capsules imprinted with "LS" on cap and "411" on body with black ink containing light yellow to yellow colored powder. NDC 70756-411-11 Bottle of 100 with child-resistant closure 100 mg blue opaque cap and blue opaque body, hard gelatin size "2" capsules imprinted with "LS" on cap and "412" on body with black ink containing light yellow to yellow colored powder. NDC 70756-412-11 Bottle of 100 with child-resistant closure Store at 20° to 25°C (68° to 77°F). [See USP for Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Manufactured for: Lifestar Pharma LLC 1200 MacArthur Blvd. Mahwah, NJ 07430 USA Made in India The other brands listed are trademarks of their respective owners and are not trademarks of Lifestar Pharma LLC. Revised: November 2022, V-03
Abbreviated New Drug Application
NITROFURANTOIN MACROCRYSTALS - NITROFURANTOIN MACROCRYSTALS CAPSULE LIFESTAR PHARMA LLC ---------- NITROFURANTOIN CAPSULES, USP (MACROCRYSTALS) RX ONLY SPL UNCLASSIFIED To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules (macrocrystals) and other antibacterial drugs, nitrofurantoin capsules (macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Nitrofurantoin capsules, USP (macrocrystals) are a synthetic chemical of controlled crystal size. It is a stable, lemon yellow, crystalline compound. Nitrofurantoin capsules, USP (macrocrystals) are an antibacterial agent for specific urinary tract infections. It is available in 25 mg, 50 mg, and 100 mg capsules for oral administration. Each capsule contains 25 mg, 50 mg, or 100 mg of nitrofurantoin, USP (macrocrystals). MOLECULAR FORMULA: C H N O MOLECULAR WEIGHT: 238.16 g/mole 1-[[(5-nitro-2-furanyl)methylene] amino]-2,4-imidazolidinedione INACTIVE INGREDIENTS: Each capsule contains: corn starch, gelatin, lactose monohydrate, talc and titanium dioxide. Additionally, each 50 mg and 100 mg capsule shell contains FD&C Blue no. 1 and FD&C Red no. 3. The capsule is printed with black pharmaceutical ink which contains ferrosoferric oxide, potassium hydroxide, and shellac. CLINICAL PHARMACOLOGY Nitrofurantoin capsules (macrocrystals) is a larger crystal form of Furadantin (nitrofurantoin). The absorption of nitrofurantoin capsules (macrocrystals) is slower and 8 6 4 5 ® ® its excretion somewhat less when compared to Furadantin . Blood concentrations at therapeutic dosage are usually low. It is highly soluble in urine; to which it may impart a brown color. Following a dose regimen of 100 mg q.i.d. for 7 days, average urinary drug recoveries (0 to 24 hours) on day 1 and day 7 were 37.9% and 35.0%. Unlike many drugs, the presence of food or agents delaying gastric emptying can increase the bioavailability of nitrofurantoin capsules (m Read the complete document